Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells

Ema Lupšić, Pavle Stojković, Marija Grozdanić, Nataša Terzić-Jovanović, Milica Pajović, Fani Koutsougianni, Dimitra Alexopoulou, Igor M Opsenica, Milica Pešić, Ana Podolski-Renić, Andrea Ragusa, Filomena Corbo · 2025

Read Novel Adamantane–Sclareol Hybrids Exploit ROS Vulnerability to Overcome Multidrug-Resistance in Glioblastoma Cells by Ema Lupšić, Pavle Stojković, Marija Grozdanić, Nataša Terzić-Jovanović, Milica Pajović, Fani Koutsougianni, Dimitra Alexopoulou, Igor M Opsenica, Milica Pešić, Ana Podolski-Renić, Andrea Ragusa, Filomena Corbo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735718.txt.

Description

New hybrid compounds that hit drug-proof brain tumors are tested by Ema Lupšić and co-authors in work dated 2025. The hybrids fuse a plant diterpene frame with a cage-like adamantane part. Six forms faced a pump-armed tumor line that shrugs off standard drugs. Three forms slipped past the pump and hit the armed cells hardest.

Two leads woke early cell death in the armed line only. They spiked harsh oxygen waste and broke the cell power core. Both also jammed the drug pump and boosted a standard drug's punch. One lead shrank tumors in mice with no weight loss.

Catalog record

CREATOREma Lupšić, Pavle Stojković, Marija Grozdanić, Nataša Terzić-Jovanović, Milica Pajović, Fani Koutsougianni, Dimitra Alexopoulou, Igor M Opsenica, Milica Pešić, Ana Podolski-Renić, Andrea Ragusa, Filomena Corbo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE60 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12735718

Browse the full library · About the Tower of Babel